Ibandronate Sodium Injection, Solution
Product Images NDC 55150-191

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Ibandronate Sodium (NDC 55150-191). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 Mean Percent Change (95% Confidence Interval) From Baseline In Lumbar Spine Bmd At One Year In Patients Treated With Ibandronate 2.5 mg Daily Oral Tablet Or Ibandronate Sodium Injection 3 mg Once Every 3 Months (Ibandronate Fig1)

A bar graph comparing lumbar spine bone mineral density (BMD) percentage increase for two dosing regimens: 2.5 mg once daily orally and 3 mg every 3 months intravenously. The intravenous 3 mg dose shows a higher BMD increase than the oral daily dose, with a statistical significance indicated (p<0.001).*

FDA Label Image

Package Label-principal Display Panel (3 mg per 3 mL (1 mg / mL))

An illustration diagram showing three sequential steps for preparing or handling a syringe device. Fig. 1 depicts a hand holding the syringe while peeling back a protective cover. Fig. 2 shows the syringe held between fingers after removing the cover. Fig. 3 presents a top view of the syringe with attached wings, likely demonstrating proper positioning or handling angle.*

FDA Label Image

Package Label-principal Display Panel (3 mg per 3 mL (1 mg / mL))

Label for Ibandronate Sodium Injection, 3 mg per 3 mL (1 mg/mL) sterile solution for intravenous use. Distributed by AuroMedics Pharma LLC, made in India. The label includes NDC 55150-191-83, barcode, and a QR code.*

FDA Label Image

Package Label-principal Display Panel (3 mg per 3 mL (1 mg / mL))

Label of Ibandronate Sodium Injection 3 mg per 3 mL (1 mg/mL) single-dose prefilled syringe. The product is sterile and for intravenous use only. Distributed by AuroMedics Pharma LLC, made in India. The label includes barcode and storage instructions at 20° to 25°C.*

FDA Label Image

Ibandronate Fig5

Packaging label for Ibandronate Sodium Injection, 3 mg per 3 mL (1 mg/mL), an intravenous injection solution. The carton includes 1 single-dose prefilled syringe and 1 needle. The product is labeled for sterile intravenous use only and is distributed by AuroMedics Pharma LLC.*

FDA Label Image

Ibandronate Sodium Chemical Structure (Ibandronate Str)

Chemical structure diagram of Ibandronate Sodium, showing the molecular formula with carbon, hydrogen, nitrogen, phosphorus, oxygen, and sodium atoms along with associated bonds and water of hydration (H2O).*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.